lupeol;Fagarasterol;Lup-20(29)-en-3b-ol;LUPEOL(AS);LUPEOL(AS) PrintBack;LUPEOL(P);LUPEOL(RG)(PLEASE CALL) PrintBack;Lupeol, froM Crataegus pinnatifida;20(29)-Lupen-3β-ol;B-VISCOL;Cautchicol;Clerodol;Fagarsterol;Lupenol;MONOGYNOL;monogynolb;β-Viscol;(3beta)-Lup-20(29)-en-3-ol;Lup-20(29)-en-3-ol;[
"Lup-20(29)-en-3-ol"
];Monogynol B
Cas No.
545-47-1
分子式
C30H50O
分子量
426.72
包装储存
Powder; -20°C; 3 years; 4°C; 2 years;
生物活性
Lupeol (Clerodol; Monogynol B; Fagarasterol) is an active pentacyclic triterpenoid, has anti-oxidant, anti-mutagenic, anti-tumor and anti-inflammatory activity. Lupeol is a potent androgen receptor (AR) inhibitor and can be used for cancer research, especially prostate cancer of androgen-dependent phenotype (ADPC) and castration resistant phenotype (CRPC).
性状
Solid
IC50 & Target[1][2]
Androgen receptor
体外研究(In Vitro)
Lupeol, an effective AR inhibitor, can be developed as a potential agent to treat humanprostate cancer (CaP). Lupeol (10–50 μM) treatment for 48 h results in a dose-dependent growth inhibition ofandrogen-dependent phenotype (ADPC) cells viz., LAPC4 and LNCaP cells with an IC50 of 15.9 and 17.3 μM, respectively. Lupeol also inhibits the growth of 22Rν_1 with an IC50 of 19.1 μM. Further, Lupeol inhibits the growth of C4-2b cells with an IC50 of 25 μM. Lupeol has the potential to inhibit the growth of CaP cells of both ADPC and CRPC phenotype. Androgens by activating AR are known to drive the growth of CaP cells.Medlife has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
Lupeol is an effective agent that has the potential to inhibit the tumorigenicity of CaP cells in vivo. At the conclusion of the study on day 56, the total circulating serum-PSA levels (secreted by the implanted tumor cells) are measured. At 56thday post-implantation, PSA levels are observed between 11.95-12.79 ng/mL in control animals with LNCaP-tumors and C4-2b-tumors, respectively. However, Lupeol-treated counterpart animals exhibits reduced serum-PSA levels in a range of 4.25-7.09 ng/mL. Tumor tissues of animals receiving Lupeol treatment exhibits reduced serum-PSA levels as compared to control.Medlife has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature or refrigerated transport.
储存方式
Powder; -20°C; 3 years; 4°C; 2 years;
ClinicalTrial
结构分类
TerpenoidsTriter
来源
Plantsother fami
溶解度数据
体外研究:Ethanol : 14.29 mg/mL(33.49 mM;ultrasonic and warming and heat to 60°C)DMSO : 2 mg/mL(4.69 mM;Need ultrasonic)配制储存液